0000899243-21-027290.txt : 20210702
0000899243-21-027290.hdr.sgml : 20210702
20210702173815
ACCESSION NUMBER: 0000899243-21-027290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210630
FILED AS OF DATE: 20210702
DATE AS OF CHANGE: 20210702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Prelack Steven
CENTRAL INDEX KEY: 0001302315
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38560
FILM NUMBER: 211071699
MAIL ADDRESS:
STREET 1: 7 WHEELWRIGHT ROAD
CITY: MEDFIELD
STATE: MA
ZIP: 02052
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerpio Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001422142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611547850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9987 CARVER ROAD
CITY: CINCINNATI
STATE: OH
ZIP: 45242
BUSINESS PHONE: (513) 985-1920
MAIL ADDRESS:
STREET 1: 9987 CARVER ROAD
CITY: CINCINNATI
STATE: OH
ZIP: 45242
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP II
DATE OF NAME CHANGE: 20071227
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-30
0
0001422142
Aerpio Pharmaceuticals, Inc.
ARPO
0001302315
Prelack Steven
C/O AERPIO PHARMACEUTICALS, INC.
9987 CARVER ROAD, SUITE 420
CINCINNATI
OH
45242
1
0
0
0
Common Stock
2021-06-30
4
A
0
12334
1.52
A
24485
D
Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended June 30, 2021.
/s/ Joseph Gardner, Attorney in Fact
2021-07-02